BioSTAR Device Achieves 90 Percent Closure Rate for Atrial Septal Defect in Children; Biodegradable Implant Avoids Risks Associated With Metal Devices

ScienceDaily (July 15, 2010) — A novel study by Canadian physicians reported that the BioSTARTM biodegradable implant achieved comparable closure rates to the Amplatzer Septal OccluderTM (ASO) in children with atrial septal defect (ASD). The BioSTAR device displayed successful outcomes, while avoiding issues associated with implants containing substantial amounts of metal.